Broker says this ASX biotech stock could almost double in value fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, and Kincell Bio, a contract development and manufacturing.
Kineticos Ventures has been busy investing as well. In late May, eXmoor pharma, a UK cell and gene therapy manufacturer partner closed on a $35 million Series A round of funding from Kineticos and one other.